Showing results 2 to 3 of 3
< previous
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Resistance monitoring data from treatment-naïve chronic HBV infected patients treated for 28 days with a new class a core protein allosteric modulator RO7049389 monotherapy Proceeding/Conference:Journal of Hepatology | 2020 | ||
| 2021 |